Skip to main content
Clinical Trials/NCT02418065
NCT02418065
Unknown
Phase 3

Multimodal Therapeutic Approach by Exercise, Oral Nutritional Supplementation, Omega 3 and Androgen in Undernourished Maintenance Hemodialysis Patients (AMERICANO)

University Hospital, Clermont-Ferrand1 site in 1 country120 target enrollmentDecember 2013

Overview

Phase
Phase 3
Intervention
training on ergonomic bicycle
Conditions
Chronic Kidney Failure
Sponsor
University Hospital, Clermont-Ferrand
Enrollment
120
Locations
1
Primary Endpoint
Change of physical endurance on bicycle
Last Updated
9 years ago

Overview

Brief Summary

The aim of the study is to evaluate a 3 months integrated multimodal therapeutic approach including exercise training program with ergocycle during dialysis sessions, oral nutritional supplementation, omega 3 and androgen, on effort tolerance and quality of life of under-nourish maintenance hemodialysis Chronic Kidney Disease (CKD) patient.

Detailed Description

The aim of the study is to evaluate a 3 months integrated multimodal therapeutic approach including exercise training program with ergocycle during dialysis sessions, oral nutritional supplementation, omega 3 and androgen, on effort tolerance and quality of life of under-nourish maintenance hemodialysis Chronic Kidney Disease (CKD) patient.

Registry
clinicaltrials.gov
Start Date
December 2013
End Date
April 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Hemodialysis patient since at least 6 month
  • Patient aged 18 years or older
  • Written consent to participate in the study
  • No acute infection or hospitalization
  • Opinion of Cardiologist saying there is no known evidence against the evaluation of the maximum exercise capacity
  • Protein-energy wasting diagnosed if at least two of this characteristics are present
  • Serum albumin \<3.8 g per 100 ml (Bromcresol Green)
  • Serum prealbumin (transthyretin) \<30mg per 100 ml
  • Reduce body mass (BMI \<23)
  • Unintentional 10% weight loss over 6 months

Exclusion Criteria

  • Presence of comorbidity which compromising the survival within 6 month
  • Unintentional low DEI \<20 kcal kg_1 day_1
  • HIV or HCV positive
  • History of hormone dependent cancer
  • Suspected or confirmed prostate cancer or breast carcinoma
  • Known hypersensitivity for testosterone
  • Presence or history of hepatic tumor
  • Inability to follow the rehabilitation program
  • Inadequate dialysis dosage (\<12 hours / week or Kt/V index\< 1,2) Pregnant or planning pregnancy and lactating women during study period
  • Adult patient protected by law

Arms & Interventions

treated group

testosteron, oral nutritional supplementation, n3 polyunsaturated fatty acid, training on ergonomic bicycle

Intervention: training on ergonomic bicycle

treated group

testosteron, oral nutritional supplementation, n3 polyunsaturated fatty acid, training on ergonomic bicycle

Intervention: Testosterone

treated group

testosteron, oral nutritional supplementation, n3 polyunsaturated fatty acid, training on ergonomic bicycle

Intervention: Oral nutritional supplementation

treated group

testosteron, oral nutritional supplementation, n3 polyunsaturated fatty acid, training on ergonomic bicycle

Intervention: n3 polyunsaturated fatty acid

control group

oral nutritional supplementation

Intervention: Oral nutritional supplementation

Outcomes

Primary Outcomes

Change of physical endurance on bicycle

Time Frame: At months 3 and 15 after inclusion

Physical endurance on bicycle at intermediate power between maximal power and ventilatory threshold power (Pmax+Pthreshold)/2

Secondary Outcomes

  • Health-related quality of life assessment using SF-36 scale and KDQOL(at day 1)
  • Karnofsky score(at ady 1)
  • determination of creatinine(µmol/L)(at 1 year)
  • Body composition(at day 1)
  • determination of urea (mmol/L)(at day 1)
  • Transthyrin serum concentration evolution(at day 1)
  • Maximal power on bicycle(at day 1)
  • Nutritional parameters(at day 1)
  • serum levels of albumin (g/L)(at day 1)

Study Sites (1)

Loading locations...

Similar Trials